Bromide

Bromide

SCHEMBL692643

C=Cc1cc[n+](CCCCCC)cc1.[Br-]

nearest known ligand 0.63

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM2 known ✓ P08172 2/20 0.55
CHRM1 known ✓ P11229 2/20 0.55
ACHE known ✓ P22303 2/20 0.55
CHRM4 known ✓ P08173 1/20 0.55
CHRM5 known ✓ P08912 1/20 0.55
CHRM3 known ✓ P20309 1/20 0.55
OPRM1 known ✓ P35372 1/20 0.52
KMT2A Q03164 5/20 0.63
HTT P42858 4/20 0.63
SMN1; SMN2 Q16637 4/20 0.63
MEN1 O00255 4/20 0.63
HSP90AA1 P07900 4/20 0.63
MAPT P10636 3/20 0.63
MAPK1 P28482 3/20 0.63
APAF1 O14727 2/20 0.63
BLM P54132 1/20 0.63
NPSR1 Q6W5P4 1/20 0.63
TP53 P04637 1/20 0.60
CYP1A2 P05177 1/20 0.60
CYP2D6 P10635 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL5586546 1.00 KMT2A (0.63) KMT2AHTTSMN1; SMN2MEN1HSP90AA1
Bromide SCHEMBL3703072 1.00 KMT2A (0.63) KMT2AHTTSMN1; SMN2MEN1HSP90AA1
Bromide SCHEMBL9819629 1.00 KMT2A (0.63) KMT2AHTTSMN1; SMN2MEN1HSP90AA1
SCHEMBL6929941 0.98 KMT2A (0.62) KMT2AHTTSMN1; SMN2MEN1HSP90AA1
SCHEMBL3392127 0.98 KMT2A (0.62) KMT2AHTTSMN1; SMN2MEN1HSP90AA1
SCHEMBL19582712 0.98 KMT2A (0.62) KMT2AHTTSMN1; SMN2MEN1HSP90AA1
SCHEMBL2786767 0.98 KMT2A (0.62) KMT2AHTTSMN1; SMN2MEN1HSP90AA1
SCHEMBL588400 0.98 KMT2A (0.62) KMT2AHTTSMN1; SMN2MEN1HSP90AA1
Hydrochloric Acid SCHEMBL8027797 0.96 KMT2A (0.60) KMT2AHTTSMN1; SMN2MEN1HSP90AA1
Hydrochloric Acid SCHEMBL9614521 0.96 KMT2A (0.60) KMT2AHTTSMN1; SMN2MEN1HSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7151139-B2 Antimicrobial polymeric surfaces MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2006-12-19 US claimed
EP-1390158-A4 ANTIMICROBIAL POLYMERIC SURFACES MASSACHUSETTS INST TECHNOLOGY (US) 2004-06-09 EP claimed
EP-1390158-A1 ANTIMICROBIAL POLYMERIC SURFACES MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2004-02-25 EP claimed
US-20030091641-A1 Antimicrobial polymeric surfaces TRUSTEES OF TUFTS COLLEGE 2003-05-15 US claimed
WO-2002085542-A1 ANTIMICROBIAL POLYMERIC SURFACES MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2002-10-31 WO claimed
US-12575768-B2 Analyte sensor antimicrobial configurations and adhesives ABBOTT DIABETES CARE, INC. (US) 2026-03-17 US disclosed
US-20240358293-A1 INCORPORATION OF SILVER SALTS WITHIN A TRANSCUTANEOUS BIOSENSOR FOR INFECTION CONTROL ABBOTT DIABETES CARE INC. (US) 2024-10-31 US disclosed
US-20220386911-A1 ANALYTE SENSOR ANTIMICROBIAL CONFIGURATIONS AND ADHESIVES ABBOTT DIABETES CARE, INC. (US) 2022-12-08 US disclosed
US-20210236028-A1 ANALYTE SENSOR ANTIMICROBIAL CONFIGURATIONS AND ADHESIVES ABBOTT DIABETES CARE INC. (US) 2021-08-05 US disclosed
EP-3793439-A1 ANALYTE SENSOR ANTIMICROBIAL CONFIGURATIONS AND ADHESIVES Abbott Diabetes Care Inc. (US) 2021-03-24 EP disclosed
US-9216158-B2 Microorganism comprising particles and uses of same MENASHE OFIR (IL) 2015-12-22 US disclosed
EP-1956899-B1 COMPOSITIONS AND METHODS FOR CELL KILLING OPLON PURE SCIENCE LTD (IL) 2015-09-09 EP disclosed
US-20080226585-A1 Method for Treating Surfaces with Copolymers INSTITUE CURIE (FR) 2008-09-18 US disclosed
EP-1956899-A1 COMPOSITIONS AND METHODS FOR CELL KILLING Sure International Ventures B.V. (NL) 2008-08-20 EP disclosed
EP-1883681-A1 METHOD FOR TREATING SURFACES WITH COPOLYMERS Université Pierre et Marie Curie (Paris VI) (FR) 2008-02-06 EP disclosed
WO-2007052270-A1 COMPOSITIONS AND METHODS FOR CELL KILLING SURE INTERNATIONAL VENTURES B.V. (NL) 2007-05-10 WO disclosed
US-20070098674-A1 Compositions and methods for cell killing OPLON B.V. (NL) 2007-05-03 US disclosed
WO-2006103631-A1 METHOD FOR TREATING SURFACES WITH COPOLYMERS INSTITUT CURIE (FR) 2006-10-05 WO disclosed
EP-1707601-A1 Method for treating surfaces with copolymers Institut Curie (FR) 2006-10-04 EP disclosed
US-5075197-A Water based polymer dispersion FUJI PHOTO FILM CO., LTD. (JP) 1991-12-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030091641-A1 Antimicrobial polymeric surfaces PUF60, PHOSPHO1, PNKP CHRM2 3283/4885CHRM1 2420/4885ACHE 945/4885
US-20080226585-A1 Method for Treating Surfaces with Copolymers EPCAM, VCAM1, ICAM1 CHRM2 1926/4885CHRM1 1210/4885ACHE 1752/4885
US-12575768-B2 Analyte sensor antimicrobial configurations and adhesives CUTA, SLC2A8, LRBA CHRM2 763/4885CHRM1 809/4885ACHE 1952/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.